glp-1 select trial 3 Takeaways from the Landmark Oral 'Switch' for Obesity Care SELECT: Glucagon-like peptide-1 receptor agonist

Prepare your documentation

Liver enzyme monitoring typically occurs every 3-6 months during the first year of treatment, then annually if results remain stable

Control group participants completed the original AUDIT questionnaire, and the participants on medications (i.e., Semaglutide or Tirzepatide) completed an adapted form asking about each question prior to and while on their medication

Include a protein source at every eating occasion including snacks

ICF syndrome is a rare autosomal recessive disease characterized by facial dysmorphism, immunoglobulin deficiency, IDD, recurrent and prolonged respiratory infections, and infections of the skin and digestive system (Valkova et al., 1987

Chen Y, Tuohy E, Krumholz H